Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory
- PMID: 29495547
- PMCID: PMC5869494
- DOI: 10.3390/v10030101
Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory
Abstract
The increasing frequency of monkeypox virus infections, new outbreaks of other zoonotic orthopoxviruses and concern about the re-emergence of smallpox have prompted research into developing antiviral drugs and better vaccines against these viruses. This article considers the genetic engineering of vaccinia virus (VACV) to enhance vaccine immunogenicity and safety. The virulence, immunogenicity and protective efficacy of VACV strains engineered to lack specific immunomodulatory or host range proteins are described. The ultimate goal is to develop safer and more immunogenic VACV vaccines that induce long-lasting immunological memory.
Keywords: genetic engineering; immune evasion; immunological memory; orthopoxviruses; smallpox; vaccine; vaccinia virus.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- WHO . The Global Eradication of Smallpox. Final Report of the Global Commission for the Certification of Smallpox Eradication. Volume 4 World Health Organization; Geneva, Switzerland: 1980.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources